Context Therapeutics Inc. (CNTX) vs Nortech Systems Incorporated (NSYS)
A side-by-side comparison of Context Therapeutics Inc. and Nortech Systems Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTX
Context Therapeutics Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
NSYS
Nortech Systems Incorporated
$11.25HealthcareDelayed quote: Oct 6, 2026, 12:16 PM EDT
Total return — CNTX vs NSYS
growth of $100 · dividends reinvested · last 5yCNTX -93.4% (-41.9%/yr)NSYS -6.8% (-1.4%/yr)NSYS compounded faster over this window
Log scale — wide-divergence pair
CNTX NSYS
CNTX vs NSYS: by the numbers
- •NSYS is the larger company ($31M vs $30M market cap).
- •NSYS is profitable (0.83% net margin) while CNTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CNTX | NSYS |
|---|---|---|
| P/E ratio | N/A | 30.59 |
| P/S ratio | N/A | 0.25 |
| P/B ratio | 0.77 | 0.89 |
| EV / EBITDA | N/A | 12.82 |
| FCF yield | N/A | 6.15% |
Profitability
| Metric | CNTX | NSYS |
|---|---|---|
| Gross margin | 0.00% | 16.44% |
| Operating margin | 0.00% | 2.02% |
| Net margin | 0.00% | 0.83% |
| ROE | -120.40% | 2.91% |
| ROIC | -126.84% | 3.16% |
Growth (annualized)
| Metric | CNTX | NSYS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.00% |
| Total return CAGR (5Y) | N/A | -1.64% |
Frequently asked
- Is CNTX or NSYS more profitable?
- NSYS runs the higher net margin — CNTX at 0.00% versus NSYS at 0.83%.
Go deeper
Dig into the metrics
Nortech Systems P/E ratioContext Therapeutics ROENortech Systems ROEContext Therapeutics operating marginNortech Systems operating marginContext Therapeutics revenue growthNortech Systems revenue growthContext Therapeutics free cash flowNortech Systems free cash flow
Context Therapeutics & Nortech Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.